MedPath

Comparing Efficiency and Stone-Free Rates Mini PCNL vs Flex URS

Not Applicable
Not yet recruiting
Conditions
Kidney Stones
Nephrolithiasis
Urolithiasis
Registration Number
NCT07072598
Lead Sponsor
Northwestern University
Brief Summary

The objective of the study is to compare the stone free rates with ureteroscopy utilizing the ClearPETRA suction ureteral access sheath, and mini-PCNL; both procedures and ClearPETRA sheaths are standard of care and are used regularly for stone treatment. Our primary objective is to assess the complete stone free rate with both procedures.

Detailed Description

With the advent of mini-PCNLs, some endourologists have been utilizing the technique to treat renal calculi up to 3cm in size with better stone free rates and similar comorbidity compared to ureteroscopy. These procedures require percutaneous renal access, and it is associated with greater length of stay and fluoroscopy time.

The ClearPETRA ureteral access sheath has shown great promise with improving stone free rates, decreasing intra-renal pressure and delivering some of the benefits of mini-PCNL without the added risk associated with obtaining percutaneous renal access.

The ClearPETRA flexible suction ureteral access sheath anecdotally improves efficiency and allows endourologists to better clear stone debris when compared to traditional ureteral access sheaths. We have yet to see a comparison between suction ureteral access sheaths and mini-PCNL with the suction renal access sheath.

Study Hypothesis: Compared to traditional access sheaths, using ClearPETRA access sheaths will result in an improvement in stone free rates with both modalities, with lower complications. Using ClearPETRA access sheaths in both modalities compared to traditional access sheaths should result in less of a difference in stone free rates between the ureteroscopy group and the mini-PCNL group.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Patients 18 years or older
  • Have a CT scan showing renal stones 1-3cm in length
  • Patients who will be able to read, understand, and complete patient questionnaires
Exclusion Criteria
  • Pregnant individuals

  • Those with anomalous renal anatomy

  • Patients with a urinary diversion (ex: Ileal conduit, reservoir, bladder substitute, etc.)

  • Any condition rendering patient medically unfit to undergo either procedure (Bleeding diasthesis)

  • Patients who lack decisional capacity

  • Patients who are non-english speakers*

    • Non-recruitment of non-english speakers is due to the study being a small pilot study that is used to assess the stone free rate for patients treated with a ureteroscopy or mini-PCNL using ClearPETRA suction access sheaths in a small portion of our patient population seeking treatment for stones. The team also does not possess the bandwidth or personnel to consent patients who are non-English speaking.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Stone free rate4 weeks post-procedure

Stone free rate (no residual stone) on post-procedure CT

Secondary Outcome Measures
NameTimeMethod
Surgery timeProcedure day (1 day)

Surgery time (minutes)

Unplanned hospital visits90 days postoperatively

Unplanned hospital visits (ED/clinic)

Need for additional procedure90 days postoperatively

Need for additional procedure (within 90 days postoperatively)

Length of stayPerioperatively (starting at Baseline/Procedure Date)

Length of stay hospital stay (if admitted post-procedure, or readmitted)

Complication rateProcedure day (1 day)

Complication rate (Clavien-Dindo) (%)

Occurrence of post-procedure sepsisPerioperatively (starting at Baseline/Procedure Date)

Post-op sepsis

Hospital / patient costs (in total for procedure and any necessary postoperative hospital admissions or procedures related to the initial procedure).Perioperatively (starting at Baseline/Procedure Date)
Inability to access ureterProcedure day (1 day)

Intra-operative complications including inability to access the ureter ureteroscopically or need to upsize the renal access sheath with the percutaneous approach.

Need to upsize from 18Fr SheathProcedure day (1 day)

Need to upsize from 18Fr (PCNL group)

Trial Locations

Locations (1)

Northwestern Memorial Hospital

🇺🇸

Chicago, Illinois, United States

Northwestern Memorial Hospital
🇺🇸Chicago, Illinois, United States
Alyssa McDonald, MPH
Contact
312-695-8146
Allaa Fadl-Alla
Contact
312-695-8146
allaafadlalla@northwestern.edu
Amy E Krambeck, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.